NanoSmart Pharmaceuticals, Inc.

Wednesday, January 16, 2013

• NanoSmart® Pharmaceuticals and UCLA Enter Collaboration Agreement for Pediatric Cancer Drug Development

  LAGUNA HILLS, Calif., Jan. 16, 2013 /PRNewswire/ -- NanoSmart Pharmaceuticals, a private biotechnology company, has entered into a research collaboration agreement with University of California Los Angeles (UCLA) to continue the development of NanoSmart's novel drug delivery platform for the treatment of cancer and other life-threatening diseases. "We ... read more